We have located links that may give you full text access.
JOURNAL ARTICLE
REVIEW
Effects of calcium silicate cements on dental pulp cells: A systematic review.
Journal of Dentistry 2018 October
OBJECTIVES: The aim of this study was to evaluate the biocompatibility, odontogenic, angiogenic and inflammatory effects of commercially available calcium silicate cements (CSCs) on dental pulp cells.
DATA: In vitro, animal and human in vivo studies reporting on biocompatibility, odontogenic, angiogenic and inflammatory effects of CSCs on dental pulp cells were screened using a systematic review, and a descriptive analysis performed.
SOURCES: We searched Medline via PubMed, Google Scholar and Scopus, followed by hand search and cross-referencing.
STUDY SELECTION: From 7007 identified studies; 38 were included. At least one MTA-type product was evaluated in each study, with ProRooT MTA being the most frequently assessed, followed by Biodentine and iRoot BP Plus. Nearly all CSCs exhibited a high biocompatibility and induced odontogenic and angiogenic effects. There was great heterogeneity in methodology and findings. In vivo, effects differed between materials; also, differences between human or animal pulp cell effects were noted. In vitro, the dilution of the cement, the period of exposure to the CSC and the specific effect measure influenced the outcomes. No CSC was clearly superior to alternatives.
CONCLUSIONS: All commercially available CSCs are biocompatible, exhibit comparable and favorable effects on odontogenic differentiation of dental pulp cells in vitro and can efficiently enhance dentin bridge formation of high quality with minimal inflammation. No specific CSC can be recommended.
CLINICAL SIGNIFICANCE: Most CSCs are highly biocompatible, promoting pulp healing at minimal pulp inflammation. While the variation in methodology limits comparisons across studies, it seems that nearly all CSCs show favorable effects on dental pulp cell. We are unable to recommend one specific material over the others.
DATA: In vitro, animal and human in vivo studies reporting on biocompatibility, odontogenic, angiogenic and inflammatory effects of CSCs on dental pulp cells were screened using a systematic review, and a descriptive analysis performed.
SOURCES: We searched Medline via PubMed, Google Scholar and Scopus, followed by hand search and cross-referencing.
STUDY SELECTION: From 7007 identified studies; 38 were included. At least one MTA-type product was evaluated in each study, with ProRooT MTA being the most frequently assessed, followed by Biodentine and iRoot BP Plus. Nearly all CSCs exhibited a high biocompatibility and induced odontogenic and angiogenic effects. There was great heterogeneity in methodology and findings. In vivo, effects differed between materials; also, differences between human or animal pulp cell effects were noted. In vitro, the dilution of the cement, the period of exposure to the CSC and the specific effect measure influenced the outcomes. No CSC was clearly superior to alternatives.
CONCLUSIONS: All commercially available CSCs are biocompatible, exhibit comparable and favorable effects on odontogenic differentiation of dental pulp cells in vitro and can efficiently enhance dentin bridge formation of high quality with minimal inflammation. No specific CSC can be recommended.
CLINICAL SIGNIFICANCE: Most CSCs are highly biocompatible, promoting pulp healing at minimal pulp inflammation. While the variation in methodology limits comparisons across studies, it seems that nearly all CSCs show favorable effects on dental pulp cell. We are unable to recommend one specific material over the others.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
Perioperative echocardiographic strain analysis: what anesthesiologists should know.Canadian Journal of Anaesthesia 2024 April 11
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app